As the demand for app-based services grows, now may be the time to invest in UX research to identify needed improvements and enhancements.
Back to team page
Kaitlin Stinson
Director
Kaitlin brings to Bold Insight over 14 years of experience as a human factors engineer at medical device manufacturers. She has extensive experience in diabetes care products, software as medical device (SaMD), and complex drug delivery systems. Kaitlin has a passion for meeting design control and regulatory requirements while executing agile human factors programs of research. She has a BS in Psychology from Ball State University and an MS in Human Factors from Bentley University.
Bold facts
Learn more about
Something unique about you summed up in one sentence:
Your favorite part of working at Bold Insight:
In your spare time (or if you had spare time), you would absolutely do this:
Your favorite city in the world is...and why?
You cannot start the day without doing this:
Your ultimate celebrity dinner party guest list would include:
Long-term personal or professional goal?
Favorite quote:
- Integrating FDA's new cybersecurity guidance into medical device human factors engineering processes
- Bold Insight and Eli Lilly and Company co-publish journal article on novel assessment tool to enhance medical device usability
- Bold Insight to launch AI research project at the 2024 HFES Health Care Symposium
Read our team’s latest bold insights
Human factors research in the times of COVID
Human factors research in the support of medical and drug delivery device commercialization is essential and we should be planning on a return to in-person research as soon as is possible by applying all available and practical protective measures.
COVID-19: Using human factors and UX to make a positive impact
We have aggregated some considerations for HCPs, healthcare organizations, and others involved in the medical space.
Is FMEA inadequate for human factors analyses?
A “traditional” risk assessment does not meet the needs of FDA-required human factors analyses.